ClinicalTrials.gov
public full text
Public Domain
Effect of the SCL16A11 Risk Haplotype on Treatments to Prevent Type 2 Diabetes
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prior SGLT2 Inhibitor and Metformin Use and Risk of Long COVID in Type 2 Diabetes: A Nationwide Population-Based Cohort Study#299094
- Screening Program for Type 1 Diabetes in a High-Risk Population#245415
- A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin#195524
- A Study of LY2189102 in Patients With Type 2 Diabetes#872762
- Group-based interventions to reduce diabetes distress in adults with type 1 diabetes: A rapid realist review of the Reduce and TunedIn interventions.#1121652
Record · ID 195541
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive